IPSEN Stock: Significant Rebound Over the Week Amid Sector Volatility
IPSEN stock has shown positive dynamics over the past week, accelerating compared to the general trend of French indices. This development occurs in a context of sector rebound and sustained activity on the stock, drawing the attention of market observers.
Over the week, IPSEN stock recorded an increase of 6.91%, closing at 131.60 euros. This rebound is part of a favorable annual trend, as the stock has shown a progression of 20.62% over the year. Capital turnover was robust, indicating significant investor interest in the stock. During the same period, the CAC 40 advanced by 2.58%, while the SBF 120 gained 2.52%, positioning IPSEN as one of the performance drivers in the healthcare sector. The monthly volatility of the stock is established at 6.99%, reflecting regular market activity and relatively stable order flow management. The support threshold has been identified at 113.10 euros, while the resistance threshold is at 131.60 euros, a level reached at the end of the week.
Technical Indicators and Market Position
Free · Every morning
Technical market signals, before the opening bell.
Bullish and bearish momentum, analyst changes, stocks to watch — automatically computed from Euronext data.
✓ Before 9 AM every morning✓ Euronext data✓ AI-powered analysis
Almost there! Check your inbox.
A confirmation email has been sent. Click the link to confirm your subscription.
An error occurred.
Indicative data. No investment advice. Unsubscribe at any time.
The stock is now trading above its 50-day and 200-day moving averages, at 118.68 euros and 109.51 euros respectively, confirming the ongoing upward momentum. The RSI indicator, positioned at 86, shows that the stock is approaching an overheating level, yet without crossing the critical threshold. The upper Bollinger band is set at 132.71 euros, while the lower band is at 113.23 euros, indicating that the price remains well contained within a volatility channel. The MACD displays a positive line, suggesting a continuation of the bullish trend in the short term. The stock's negative beta of -0.09 indicates a low correlation with general market movements, which could be explained by factors specific to the sector or the company.
"En 2025, Ipsen a enregistré une croissance solide de son chiffre d'affaires et de son résultat opérationnel."
Ipsen a publié ses résultats 2025 et T4 2025: chiffre d'affaires de 3 675,9 millions d'euros, croissance YoY de 8,1%; Résultat opérationnel des activités de 1 294,1 millions d'euros, marge de 35,2%; Résultat net consolidé IFRS de 444,5 millions d'euros; Bénéfice dilué par action IFRS de 5,32 euros; Cash-flow libre de 1 000,6 millions d'euros; Dividende par action de 1,40 euro.
Outlook / guidance
Expected revenue: Une croissance des ventes totales supérieure à 13,0 % à taux de change constant en 2026
Management commentary: Ipsen prévoit en 2026 une croissance des ventes totales supérieure à 13,0% à taux de change constant et une marge opérationnelle des activités supérieure à 35,0%.
The information presented in this article is provided for informational purposes only and does not constitute an investment recommendation, an incentive to buy or sell a financial asset, or investment advice. Readers are invited to conduct their own research before making any decision.
Investments in the stock market involve risks, including the risk of capital loss. Past performance of an asset or market is no guarantee of future results. Any investment decision should be made taking into account your personal financial situation, objectives and risk tolerance.
